Delivery Order SPE2DX15D1021-SPE2DX22FHSFA
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,775.89, is for the delivery of 100 capsules of the medication Tacrolimus 5 mg. The contract has a performance period that extends through May 8, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order, valued at $4,361.18, is for the provision of 100 units of the pharmaceutical drug Tacrolimus 1 mg capsules. This order falls under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tacrolimus 1 mg capsules, an immunosuppressant medication, with a ceiling value of $8,462.05 and a period of performance through June 24, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Tacrolimus 1 mg capsules, an immunosuppressant medication. The delivery order has a ceiling value of $2,488.03 and a completion date of July 11, 2025. The contract is a firm fixed-price type and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,831.34 delivery order is for 100 capsules of the prescription drug Tacrolimus 1 mg, an immunosuppressant medication. The contract is a firm-fixed price Delivery Order with a completion date of December 30, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $14,773.24 firm-fixed-price contract is for the delivery of Tacrolimus 5 mg capsules, an immunosuppressant medication. The contract has a period of performance through June 11, 2025 and is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,814.04 firm fixed-price contract is for the supply of 100 capsules of 1 mg Tacrolimus, an immunosuppressant medication commonly used in organ transplant patients. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Tacrolimus 1 mg capsules (100-count units) with a contract ceiling value of $1,206.33. This firm fixed-price delivery order, with an ultimate completion date of July 31, 2025, represents a non-set-aside competitive award executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is to provide Tacrolimus 1 mg capsules, an immunosuppressant drug, in 100-count unit doses. The contract has a potential value of $1,382.94 and a completion date of January 3, 2024. This delivery order is part of a larger indefinite delivery contract held by Amerisourcebergen Drug Corp to supply pharmaceuticals and...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,767.09, is for the delivery of TACROLIMUS 1 MG CAPSULE (IR) 100S, a medication used for various medical treatments. The contract is a Delivery Order awarded under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- SPE2DX15D1021Indefinite Delivery Contract
- SPE2DX15D1021-SPE2DX22FHSFADelivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of 100 capsules of 1 mg Tacrolimus, an immunosuppressant drug used to prevent organ rejection. The contract has a potential value of $4,745.90 and a completion date of May 5, 2022. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 5/4/22 |